Trial Paper

Blood biomarker changes and relationships after low dose oral ketamine treatment for post-traumatic stress disorder (PTSD)

Authors

Published

March 16, 2026

individual Study

Links

Read Paper DOI Google Scholar

Unlocked with Blossom Pro

Research Summary of 'Blood biomarker changes and relationships after low dose oral ketamine treatment for post-traumatic stress disorder (PTSD)'

Full Text PDF

Open PDF in new tab

Study Details

Study Type
individual

Related Clinical Trial

RecruitingPhase II

The Effect of Transcranial Magnetic Stimulation and Oral Ketamine Combination Treatment on severity of symptoms in Post-Traumatic Stress Disorder (TMS-OK PTSD)

This double-blinded, randomised controlled trial (n=100) aims to assess the feasibility, tolerability, and safety of intermittent theta burst stimulation (iTBS) and oral ketamine (OK) as a combination treatment for Post-Traumatic Stress Disorder (PTSD).

Started: July 8, 2021
Type: interventional
Blinding: single
Randomized: Yes
Registry ID: ACTRN12621000342819

Your Library